| Bioconda: sustainable and comprehensive software distribution for the life sciences B Grüning, R Dale, A Sjödin, BA Chapman, J Rowe, CH Tomkins-Tinch, ... Nature methods 15 (7), 475-476, 2018 | 1559 | 2018 |
| Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial A Sartore-Bianchi, S Lonardi, C Martino, E Fenocchio, F Tosi, S Ghezzi, ... ESMO open 5 (5), e000911, 2020 | 184 | 2020 |
| Prediction of human disease genes by human-mouse conserved coexpression analysis U Ala, RM Piro, E Grassi, C Damasco, L Silengo, M Oti, P Provero, ... PLoS computational biology 4 (3), e1000043, 2008 | 171 | 2008 |
| Rehabilitating patients with left spatial neglect by prism exposure during a visuomotor activity. P Fortis, A Maravita, M Gallucci, R Ronchi, E Grassi, I Senna, E Olgiati, ... Neuropsychology 24 (6), 681, 2010 | 156 | 2010 |
| Towards precision oncology with patient-derived xenografts ER Zanella, E Grassi, L Trusolino Nature reviews Clinical oncology 19 (11), 719-732, 2022 | 145 | 2022 |
| Chromatin Velocity reveals epigenetic dynamics by single-cell profiling of heterochromatin and euchromatin M Tedesco, F Giannese, D Lazarević, V Giansanti, D Rosano, S Monzani, ... Nature biotechnology 40 (2), 235-244, 2022 | 130 | 2022 |
| miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation E Penna, F Orso, D Cimino, I Vercellino, E Grassi, E Quaglino, E Turco, ... Cancer research 73 (13), 4098-4111, 2013 | 116 | 2013 |
| BRAF inactivation drives aneuploidy by deregulating CRAF T Kamata, J Hussain, S Giblett, R Hayward, R Marais, C Pritchard Cancer research 70 (21), 8475-8486, 2010 | 106* | 2010 |
| miR-214 and miR-148b targeting inhibits dissemination of melanoma and breast cancer F Orso, L Quirico, F Virga, E Penna, D Dettori, D Cimino, R Coppo, ... Cancer research 76 (17), 5151-5162, 2016 | 86 | 2016 |
| An atlas of tissue-specific conserved coexpression for functional annotation and disease gene prediction RM Piro, U Ala, I Molineris, E Grassi, C Bracco, GP Perego, P Provero, ... European Journal of Human Genetics 19 (11), 1173-1180, 2011 | 67 | 2011 |
| Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype B Lupo, F Sassi, M Pinnelli, F Galimi, ER Zanella, V Vurchio, G Migliardi, ... Science translational medicine 12 (555), eaax8313, 2020 | 64 | 2020 |
| Roar: detecting alternative polyadenylation with standard mRNA sequencing libraries E Grassi, E Mariella, A Lembo, I Molineris, P Provero BMC bioinformatics 17 (1), 423, 2016 | 58 | 2016 |
| Choice of alternative polyadenylation sites, mediated by the RNA-binding protein Elavl3, plays a role in differentiation of inhibitory neuronal progenitors E Grassi, R Santoro, A Umbach, A Grosso, S Oliviero, F Neri, L Conti, ... Frontiers in cellular neuroscience 12, 518, 2019 | 55 | 2019 |
| Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer SB Malla, RM Byrne, MW Lafarge, SM Corry, NC Fisher, PK Tsantoulis, ... Nature Genetics 56 (3), 458-472, 2024 | 51 | 2024 |
| Quality of life and aphasia. Multicentric standardization of a questionnaire. L Posteraro, A Formis, E Grassi, M Bighi, P Nati, C Proietti Bocchini, ... Europa medicophysica 42 (3), 227-230, 2006 | 47 | 2006 |
| Evolutionary rewiring of human regulatory networks by waves of genome expansion D Marnetto, F Mantica, I Molineris, E Grassi, I Pesando, P Provero The American Journal of Human Genetics 102 (2), 207-218, 2018 | 44 | 2018 |
| Aphasia quality of life: reliability of the Italian version of SAQOL-39 L Posteraro, A Formis, C Bidini, E Grassi European Journal of Physical and Rehabilitation Medicine 40 (4), 257, 2004 | 43 | 2004 |
| Evolution of promoter affinity for transcription factors in the human lineage I Molineris, E Grassi, U Ala, F Di Cunto, P Provero Molecular biology and evolution 28 (8), 2173-2183, 2011 | 37 | 2011 |
| Genome-wide identification and characterization of fixed human-specific regulatory regions D Marnetto, I Molineris, E Grassi, P Provero The American Journal of Human Genetics 95 (1), 39-48, 2014 | 36 | 2014 |
| The length of the expressed 3′ UTR is an intermediate molecular phenotype linking genetic variants to complex diseases E Mariella, F Marotta, E Grassi, S Gilotto, P Provero Frontiers in genetics 10, 714, 2019 | 34 | 2019 |
